IDEXX Laboratories Financials

0J8P Stock   434.17  3.78  0.86%   
We strongly advise to harness IDEXX Laboratories fundamental analysis to see if markets are right now undervaluing or overvaluing the company. Simply put, you can make use of it to find out if IDEXX Laboratories is indeed mispriced or if you can make any profits on it by purchasing it and then waiting for the market to recognize its mistake and reprise the security. We are able to interpolate and collect twenty-four available reported financial drivers for IDEXX Laboratories, which can be compared to its competitors. The stock experiences a moderate downward daily trend and can be a good diversifier. Check odds of IDEXX Laboratories to be traded at 425.49 in 90 days. Key indicators impacting IDEXX Laboratories' financial strength include:
Current ValueLast YearChange From Last Year 10 Year Trend
Operating Income1.2 B1.1 B
Sufficiently Up
Slightly volatile
  
Understanding current and past IDEXX Laboratories Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of IDEXX Laboratories' financial statements are interrelated, with each one affecting the others. For example, an increase in IDEXX Laboratories' assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in IDEXX Laboratories' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of IDEXX Laboratories. Check IDEXX Laboratories' Beneish M Score to see the likelihood of IDEXX Laboratories' management manipulating its earnings.

IDEXX Laboratories Stock Summary

IDEXX Laboratories competes with Atalaya Mining, Trainline Plc, Anglesey Mining, Broadcom, and Endeavour Mining. IDEXX Laboratories is entity of United Kingdom. It is traded as Stock on LSE exchange.
Specialization
Industrials, Commercial & Professional Services
InstrumentUK Stock View All
ExchangeLondon Exchange
Business AddressOne IDEXX Drive,
SectorCommercial Services & Supplies
IndustryIndustrials
BenchmarkDow Jones Industrial
Websitewww.idexx.com
Phone207 556 0300
You should never invest in IDEXX Laboratories without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of IDEXX Stock, because this is throwing your money away. Analyzing the key information contained in IDEXX Laboratories' financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.

IDEXX Laboratories Key Financial Ratios

There are many critical financial ratios that IDEXX Laboratories' investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that IDEXX Laboratories reports annually and quarterly.

IDEXX Laboratories Key Balance Sheet Accounts

201920202021202220232024 (projected)
Total Assets1.8B2.3B2.4B2.7B3.3B3.4B
Other Current Liab276.5M355.2M396.4M364.7M372.4M391.0M
Net Debt897.3M524.6M779.2M1.2B613.4M644.1M
Retained Earnings1.6B2.2B2.9B3.6B4.4B4.7B
Accounts Payable72.2M74.6M116.1M110.2M110.6M116.2M
Cash90.3M383.9M144.5M112.5M453.9M476.6M
Net Receivables307.5M374.7M425.6M490.9M529.5M556.0M
Inventory195.0M209.9M269.0M367.8M380.3M399.3M
Other Current Assets86.8M94.2M116.6M130.2M131.5M75.1M
Total Liab1.7B1.7B1.7B2.1B1.8B1.9B
Total Current Assets679.6M1.1B955.7M1.1B1.5B1.6B
Intangible Assets58.5M52.5M99.0M97.7M84.5M66.7M
Short Term Debt304.0M67.7M168.4M674.4M344.8M212.2M
Common Stock10.6M10.6M10.7M10.7M10.8M9.2M
Good Will239.7M243.3M359.3M361.8M366.0M218.6M
Other Assets240.2M289.6M325.2M1.01.151.09
Other Liab162.9M143.5M121.0M106.6M95.9M115.4M
Net Tangible Assets(120.7M)336.2M231.6M149.3M171.7M180.2M
Long Term Debt499.6M599.5M858.5M775.2M891.5M711.1M

IDEXX Laboratories Key Income Statement Accounts

201920202021202220232024 (projected)
Total Revenue2.4B2.7B3.2B3.4B3.7B3.8B
Gross Profit1.4B1.6B1.9B2.0B2.2B2.3B
Operating Income552.8M694.5M932.0M898.8M1.1B1.2B
Ebit555.7M697.8M935.3M902.6M1.1B1.2B
Ebitda643.7M793.8M1.0B1.0B1.2B1.3B
Cost Of Revenue1.0B1.1B1.3B1.4B1.5B1.5B
Income Before Tax522.2M662.0M902.7M860.0M1.1B1.1B
Net Income427.7M581.8M744.8M679.1M845.0M887.3M
Income Tax Expense94.4M79.9M157.8M180.9M216.1M226.9M
Research Development133.2M141.2M161.0M254.8M191.0M200.5M
Interest Expense30.6M32.5M29.4M38.8M41.6M43.7M
Tax Provision78.6M94.4M79.9M157.8M181.5M109.4M
Interest Income33.6M30.6M32.5M29.4M26.4M25.3M

IDEXX Laboratories Key Cash Accounts

201920202021202220232024 (projected)
Change To Inventory(37.3M)(18.9M)(52.9M)(121.7M)(28.7M)(27.2M)
Change In Cash(33.5M)293.6M(239.5M)(31.9M)341.4M358.5M
Free Cash Flow303.9M540.4M636.0M394.1M772.9M811.5M
Depreciation88.0M96.0M104.6M111.9M114.9M120.7M
Other Non Cash Items2.9M8.8M9.3M10.8M7.6M7.9M
Capital Expenditures155.2M107.6M119.5M148.8M133.6M140.3M
Net Income427.8M582.1M744.8M679.1M845.0M887.3M
End Period Cash Flow90.3M383.9M144.5M112.5M453.9M476.6M
Net Borrowings(10.3M)(89.6M)23.5M430.5M495.1M519.8M
Change To Netincome48.4M2.1M43.6M25.5M29.4M31.1M

IDEXX Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining IDEXX Laboratories's current stock value. Our valuation model uses many indicators to compare IDEXX Laboratories value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across IDEXX Laboratories competition to find correlations between indicators driving IDEXX Laboratories's intrinsic value. More Info.
IDEXX Laboratories is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about  0.38  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for IDEXX Laboratories is roughly  2.61 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the IDEXX Laboratories' earnings, one of the primary drivers of an investment's value.

IDEXX Laboratories Systematic Risk

IDEXX Laboratories' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. IDEXX Laboratories volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Beta measures systematic risk based on how returns on IDEXX Laboratories correlated with the market. If Beta is less than 0 IDEXX Laboratories generally moves in the opposite direction as compared to the market. If IDEXX Laboratories Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one IDEXX Laboratories is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of IDEXX Laboratories is generally in the same direction as the market. If Beta > 1 IDEXX Laboratories moves generally in the same direction as, but more than the movement of the benchmark.

IDEXX Laboratories Total Assets Over Time

IDEXX Laboratories December 15, 2024 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of IDEXX Laboratories help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of IDEXX Laboratories. We use our internally-developed statistical techniques to arrive at the intrinsic value of IDEXX Laboratories based on widely used predictive technical indicators. In general, we focus on analyzing IDEXX Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build IDEXX Laboratories's daily price indicators and compare them against related drivers.

Additional Tools for IDEXX Stock Analysis

When running IDEXX Laboratories' price analysis, check to measure IDEXX Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy IDEXX Laboratories is operating at the current time. Most of IDEXX Laboratories' value examination focuses on studying past and present price action to predict the probability of IDEXX Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move IDEXX Laboratories' price. Additionally, you may evaluate how the addition of IDEXX Laboratories to your portfolios can decrease your overall portfolio volatility.